Jeong-Ok Lee

机构：Seoul National University Bundang Hospital

发表论文 1 篇

代表论文

• Bosmolisib (BR101801), a novel PI3K-δ/γ and DNA-PK inhibitor for relapsed/refractory patients with peripheral T-cell lymphoma: a phase I study (2026 · Blood Cancer Journal)